Tag: Coronavirus

Doctor Cleavon Gilman says an Arizona hospital retaliated against him for tweeting about coronavirus

The tweet swiftly went viral, helping to propel Gilman to such prominence that President-elect Joe Biden later called to thank him for his advocacy. The next day, though, he says the hospital told the third-party company that he works through that it didn’t want him to return. Gilman, 41, says he’s been kept out of work since Nov. 23.

“The hospital is intentionally hurting me financially for speaking out, and I’m not permitted to work,” Gilman told The Washington Post on Thursday.

The hospital, though, insists that Gilman hasn’t been fired and in fact is scheduled to return to the ER this weekend.

“It’s clear there has been a misunderstanding,” Shay Andres, a Yuma Regional Medical Center spokeswoman, said in an email statement early Friday. “While he is not speaking on behalf of YRMC, we respect Dr. Gilman’s right to share his personal perspective on the pandemic.”

Gilman, in response,

Read More
2-drug treatment helpful for coronavirus

BOSTON — Doctors are reporting that a two-drug treatment is especially helpful for COVID-19 patients who need extra oxygen.

Adding the anti-inflammatory drug baricitinib to the antiviral medicine remdesivir helped these patients recover eight days sooner, in 10 days on average versus 18 for those given remdesivir alone, according to a study.

The medicines have been recommended since September, when early results from this U.S. government-sponsored study suggested the combination shortened recovery time for hospitalized patients by one day.

Full results published Friday by the New England Journal of Medicine show the benefit was even greater for those needing oxygen or other respiratory support short of a breathing machine. Serious side effects and new infections also were fewer in the combo treatment group.

The study involved more than 1,000 COVID-19 patients. All were given Gilead Sciences’ remdesivir, sold as Veklury, and half also received baricitinib, a drug Eli Lilly sells

Read More
The Health 202: The FDA could okay the first coronavirus vaccines any time now

Advisers to the Food and Drug Administration have agreed Pfizer’s coronavirus vaccine is safe enough to use.

At the end of a day-long meeting yesterday, the 15-member Vaccines and Related Biological Products Advisory Committee was asked to consider this statement: “Based on the totality of scientific evidence available, do the benefits of the Pfizer-BioNTech Covid-19 vaccine outweigh its risks for use in individuals 16 years of age and older?”

The members voted 17-to-4 in favor of that statement, with one member abstaining.

The vote makes it all but certain the FDA will authorize the vaccine on an emergency use basis within hours or days, kicking off an unprecedented effort to inoculate enough Americans to stop the rampaging pandemic, my colleagues Laurie McGinley and Carolyn Y. Johnson write.

If as expected, the FDA follows quickly with an emergency authorization, the shots will start being moved to the states within 24

Read More
How Coronavirus Transformed Meditation From A Management Fad Into An Essential Business Tool

Mindfulness came of age in 2020. In the grueling, fearful months of this global pandemic, organizations had an epiphany: support for employee wellbeing is a must-have, not just a nice to have. The need for increased focus and resilience, especially by managers, has been obvious. The meditation app Headspace reports more than a 500% increase in companies seeking mental health assistance for their workforce. Medical prescriptions for digital therapy apps have increased by 6,500%. Before Covid-19, it was predicted the mindfulness industry would grow to be worth $2billion a year. This figure is now likely to be far larger. 

Amid Coronavirus, mindfulness has metamorphosed. It began as a hyper-trendy Silicon Valley fad in the early part of the century. It’s now an essential leadership development tool for stressed-out managers in companies from De Moines to Düsseldorf.

Mindfulness is the practice of paying attention on purpose to the present moment, non-judgmentally.

Read More
HHS Head Alex Azar: Feds Eye Monday or Tuesday for First Coronavirus Vaccine Shots | Health News

Officials expect to begin vaccinating Americans against the coronavirus early next week, according to Health and Human Services Secretary Alex Azar.

“We could see people getting vaccinated Monday, Tuesday of next week,” Azar said on ABC’s “Good Morning America” on Friday.

Azar’s comments come after a Food and Drug Administration advisory committee on Thursday voted in favor of issuing a vaccine developed by Pfizer and BioNTech an emergency use authorization.

Cartoons on the Coronavirus

The Vaccines and Related Biological Products Advisory Committee voted 17-4 with one person abstaining that the benefits of the vaccine outweigh the risks for individuals 16 years of age and older.

FDA Commissioner Stephen Hahn said Friday that the agency is “rapidly” working on issuing an emergency use authorization.

“Following yesterday’s positive advisory committee meeting outcome regarding the Pfizer-BioNTech COVID-19 vaccine, the U.S. Food and Drug Administration has informed the sponsor that it will rapidly work

Read More